Heat Therapy and Strength Training Effects in Individuals With Type 2 Diabetes
Effect of Heat Therapy Compared With Strength Training on Metabolic Profile, Heat Shock Response, Inflammation, Cardiovascular Responses and Microbiota in Individuals With Type 2 Diabetes
1 other identifier
interventional
66
1 country
2
Brief Summary
The aim of this study is to compare different non-pharmacological interventions in Type 2 diabetic people, testing their efficiency to improve metabolism and inflammation. The investigators will compare the effects of Heat Therapy (HT) and Strength training (ST), for 12 weeks, to test which one is more effective to improve participants health. Heat Therapy consists in submitting a person to an environmental chamber, initially set at 55 degrees Celsius on three non-consecutive days of the week. Each session will last 60 min. ST consists in supervised exercise in a gym on three non-consecutive days of the week. Each session will last \~60 min and will consist of a warm up, the resistance training and a cool down. All sessions will be conducted by qualified sport and exercise scientists for 12 weeks. A third group of people will stay sedentary without any other intervention for 12 weeks. Before, and after the end of the intervention blood samples will be collected to analyze metabolic parameters as well as inflammatory markers. The investigators hypothesize that ST and HT will reduce HbA1c levels, improve metabolic and inflammatory profile, dysbiosis, and the anti-inflammatory heat shock response (HSR).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable type-2-diabetes
Started Jul 2023
Typical duration for not_applicable type-2-diabetes
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 11, 2023
CompletedFirst Posted
Study publicly available on registry
May 6, 2023
CompletedStudy Start
First participant enrolled
July 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2026
CompletedMay 6, 2023
May 1, 2023
1.5 years
April 11, 2023
May 3, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Plasma HSP72
Plasma concentration (in ng/mL) of HSP72.
First visit, prior to the intervention (baseline) AND 2 weeks of intervention.
Secondary Outcomes (9)
Fasting glucose
First visit, prior to the intervention (baseline) AND 12 weeks of intervention.
Insulin plasma concentration
First visit, prior to the intervention (baseline) AND 12 weeks of intervention.
Insulin resistance (HOMA-IR)
First visit, prior to the intervention (baseline) AND 12 weeks of intervention.
Body Mass Index (kg·m-2)
First visit, prior to the intervention (baseline) AND 12 weeks of intervention.
Visceral adipose tissue (VAT)
First visit, prior to the intervention (baseline) AND 12 weeks of intervention.
- +4 more secondary outcomes
Study Arms (3)
Sedentary Diabetic people
EXPERIMENTALSedentary people with Type 2 Diabetes.
Heat Therapy
EXPERIMENTALDiabetic people allocated in Heat Therapy for 12 weeks.
StrengthTraining
EXPERIMENTALDiabetic people allocated in Strength training for 12 weeks.
Interventions
Participants in the HT group will undertake whole body heat treatment according to previous methods. Participants will be housed in an environmental chamber initially set at 55.0oC on three non-consecutive days of the week during 12 weeks. Each session will last 60 min.
Participants will perform supervised exercise in a gym on three non-consecutive days of the week. Each session will last \~60 min and will consist of a warm up, the resistance training and a cool down. All sessions will be conducted by qualified sport and exercise scientists for 12 weeks.
Participants will not receive any intervention during 12 weeks.
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of type 2 diabetes
- HbA1c levels were between 7.0% and 10%
- Sedentary
- Non-smoking
- Body mass index (BMI) between 18.5-39.9 kg/m2,
- No use of insulin.
You may not qualify if:
- Pregnancy or breastfeeding
- Under treatment with antibiotics or anti-inflammatory drugs within 4 weeks,
- History of cardiovascular diseases: myocardial infarction, cardiac illness, vascular disease, stroke, or any condition that would prevent them from engaging in an exercise study;
- Engaged in two or more planned and structured exercise sessions per week (in the last six months).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Universidade Federal do Rio Grande do Sul
Porto Alegre, Rio Grande do Sul, 90040-060, Brazil
Universidade Federal do Rio Grande do Sul
Porto Alegre, 90035-003, Brazil
Related Publications (1)
Bock PM, Kowalewski LS, Ayres LR, Russo MKB, Leites GT, Martins AF, Oliveira AR, Krause M. Effect of heat therapy compared with strength training on metabolic profile, heat shock response, inflammation, cardiovascular responses and microbiota in individuals with type 2 diabetes: study protocol of a randomized trial. Sao Paulo Med J. 2025 Jun 2;143(3):e2024040. doi: 10.1590/1516-3180-2024.0040.R1.13082024. eCollection 2025.
PMID: 40465937DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mauricio Krause, PhD
Federal University of Rio Grande do Sul
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Due to the nature of the interventions, the researcher conducting the exercise sessions as well as participants will not be blinded. To ensure assessor masking, the subjects are asked to omit their assigned group and not to talk about their interventions during the outcome evaluation sessions. In the case of unintentional unblinding for any reason, the involved researcher will notify the principal researcher.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 11, 2023
First Posted
May 6, 2023
Study Start
July 1, 2023
Primary Completion
January 15, 2025
Study Completion
January 15, 2026
Last Updated
May 6, 2023
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share